KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Inventory (2016 - 2025)

Quest Diagnostics' Inventory history spans 17 years, with the latest figure at $189.0 million for Q4 2025.

  • For Q4 2025, Inventory rose 0.53% year-over-year to $189.0 million; the TTM value through Dec 2025 reached $189.0 million, up 0.53%, while the annual FY2025 figure was $189.0 million, 0.53% up from the prior year.
  • Inventory for Q4 2025 was $189.0 million at Quest Diagnostics, up from $186.0 million in the prior quarter.
  • Across five years, Inventory topped out at $223.0 million in Q1 2021 and bottomed at $181.0 million in Q1 2024.
  • The 5-year median for Inventory is $188.5 million (2024), against an average of $191.4 million.
  • The largest annual shift saw Inventory surged 76.98% in 2021 before it decreased 11.66% in 2022.
  • A 5-year view of Inventory shows it stood at $208.0 million in 2021, then decreased by 7.69% to $192.0 million in 2022, then decreased by 1.04% to $190.0 million in 2023, then dropped by 1.05% to $188.0 million in 2024, then increased by 0.53% to $189.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Inventory are $189.0 million (Q4 2025), $186.0 million (Q3 2025), and $187.0 million (Q2 2025).